Office evaluation and management of bladder neoplasms

Area of Science:

• Uro-oncology
• Neoplastic disease research

Background:

• Transitional cell carcinoma is the most common bladder cancer.
• Bladder tumors exhibit heterogeneity, necessitating risk-based management strategies.
• Current surveillance relies heavily on cystoscopy, with ongoing research into improved tumor markers.

Purpose of the Study:

• To outline a risk-stratified management approach for transitional cell carcinoma.
• To highlight the importance of personalized treatment and surveillance protocols.
• To discuss current and emerging diagnostic and therapeutic modalities.

Main Methods:

• Standard initial evaluation includes cystoscopy and intravenous pyelogram (IVP).
• Intravesical chemotherapy and immunotherapy are used for recurrence reduction.
• Laser fulguration is employed for low-grade neoplasms under local anesthesia.
• Surveillance for superficial disease primarily uses office-based cystoscopy.

Main Results:

• Risk stratification guides management, avoiding unnecessary interventions for low-risk patients.
• Office-based treatments like intravesical chemotherapy and laser fulguration are effective.
• Tumor markers show potential for reducing surveillance cystoscopies.
• Post-cystectomy follow-up focuses on recurrence, metastasis, and diversion-related complications.

Conclusions:

• Risk stratification is crucial for effective and efficient transitional cell carcinoma management.
• Minimally invasive office-based procedures enhance treatment delivery and patient convenience.
• Advancements in tumor markers and surveillance techniques are needed to refine patient follow-up.